These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 14622330)
1. An 82-year-old man with an implantation of a CPI Ventak AV II DR device for sustained ventricular tachycardia. Marieb MA; Schwartz KV Pacing Clin Electrophysiol; 2003 Nov; 26(11):2209. PubMed ID: 14622330 [No Abstract] [Full Text] [Related]
2. Inappropriate shock therapy for nonsustained ventricular tachycardia in a dual chamber pacemaker defibrillator. Mann DE; Kelly PA; Reiter MJ Pacing Clin Electrophysiol; 1998 Oct; 21(10):2005-6. PubMed ID: 9793101 [TBL] [Abstract][Full Text] [Related]
3. [Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases]. Le Franc P; Klug D; Lacroix D; Kouakam C; Jarwé M; Kacet S Arch Mal Coeur Vaiss; 1998 Jun; 91(6):739-44. PubMed ID: 9749190 [TBL] [Abstract][Full Text] [Related]
4. A case of exhaustion of implantable cardioverter defibrillator therapies due to inappropriate programming. Fragakis NK; Antoniadis AP; Geleris P Hellenic J Cardiol; 2011; 52(4):354-6. PubMed ID: 21933768 [TBL] [Abstract][Full Text] [Related]
5. Experience with three different third-generation cardioverter-defibrillators in patients with coronary artery disease or cardiomyopathy. Porterfield JG; Porterfield LM; Smith BA; Bray L Am J Cardiol; 1993 Aug; 72(3):301-4. PubMed ID: 8342508 [TBL] [Abstract][Full Text] [Related]
6. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation. Lo R; Mitrache A; Quan W; Cohen TJ J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178 [TBL] [Abstract][Full Text] [Related]
7. Failure of an implantable cardioverter defibrillator to terminate ventricular tachycardia: why? Conti L; Tran N; Burri H; Zimmermann M Pacing Clin Electrophysiol; 2010 Feb; 33(2):228-30. PubMed ID: 19821932 [No Abstract] [Full Text] [Related]
8. A randomized controlled clinical trial comparing ventricular fibrillation detection time between two transvenous defibrillator models. The Acute Ventak AV investigator group. Kühlkamp V; Mortensen P; Kirstein P; den Dulk K; Hoffman E; Wilber D; Higgins S; Kühl M Pacing Clin Electrophysiol; 1999 Jul; 22(7):990-8. PubMed ID: 10456626 [TBL] [Abstract][Full Text] [Related]
9. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators. Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190 [TBL] [Abstract][Full Text] [Related]
10. Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. The VENTAK PRx Phase I Investigators. Porterfield JG; Porterfield LM; Smith BA; Bray L; Voshage L; Martinez A Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):170-3. PubMed ID: 7681566 [TBL] [Abstract][Full Text] [Related]
11. [Experiences with the new cardioverter-defibrillator Ventak PRxII]. Pfitzner P; Trappe HJ; Fieguth HG; Kielblock B Z Kardiol; 1995 Apr; 84(4):275-83. PubMed ID: 7785299 [TBL] [Abstract][Full Text] [Related]
12. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator]. Kühlkamp V; Dörnberger V; Mermi J; Mewis C; Seipel L Z Kardiol; 1996 May; 85(5):306-11. PubMed ID: 8711942 [TBL] [Abstract][Full Text] [Related]
13. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Lampert R; Rosenfeld L; Batsford W; Lee F; McPherson C Circulation; 1994 Jul; 90(1):241-7. PubMed ID: 8026004 [TBL] [Abstract][Full Text] [Related]
14. Initial clinical experience with a new small sized third-generation implantable cardioverter defibrillator: results of a multicenter study. European Ventak Mini Investigator Group. Fenelon G; Huvelle E; Brugada P Pacing Clin Electrophysiol; 1997 Dec; 20(12 Pt 1):2967-74. PubMed ID: 9455759 [TBL] [Abstract][Full Text] [Related]
15. [Transvenous cardioverter-defibrillators: clinical experience at implantation and follow-up]. Boriani G; Frabetti L; Capucci A; Galli R; Parlapiano M; Biffi M; Sabbatani P; Spedicato L; Bronzetti G; Pierangeli A Cardiologia; 1995 Jun; 40(6):381-9. PubMed ID: 8640850 [TBL] [Abstract][Full Text] [Related]
16. [Twiddler syndrome: a rare complication of ICD implantation]. Waśniewski M; Mitkowski P; Stanek K; Ochotny R; Cieśliński A Kardiol Pol; 2007 Sep; 65(9):1094-6. PubMed ID: 17975757 [TBL] [Abstract][Full Text] [Related]
17. [Complication after implantable cardioverter defibrillator implantation: report of 1 case]. Lou ZY; Zhou MH; Li XQ Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642 [No Abstract] [Full Text] [Related]
18. Initial experience with a new transvenous defibrillation system. Trappe HJ; Klein H; Fieguth HG; Kielblock B; Wenzlaff P; Lichtlen PR Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):134-40. PubMed ID: 7681560 [TBL] [Abstract][Full Text] [Related]
19. Implantation of an epicardial dual chamber ICD following unsuccessful percutaneous extraction of a failed ventricular shocking electrode. Adlam D; Cubbon RM; Skehan D Pacing Clin Electrophysiol; 2004 May; 27(5):686-7. PubMed ID: 15125733 [TBL] [Abstract][Full Text] [Related]
20. Using left-ventricular-only pacing to eliminate T-wave oversensing in a biventricular implantable cardiac defibrillator. Khoo C; Bennett M; Chakrabarti S; LeMaitre J; Tung SK Can J Cardiol; 2013 Feb; 29(2):254.e5-7. PubMed ID: 22902157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]